Screener
PVAL vs PCRB
Putnam Focused Large Cap Value ETF vs Putnam ESG Core Bond ETF -
Key differences
- PCRB costs 0.19% less per year.
- PVAL is significantly larger than PCRB — larger funds tend to be more liquid and less likely to close.
- PVAL is classified as equity, while PCRB is fixed income — different risk/return profiles.
- PVAL follows a active selection strategy; PCRB uses index tracking.
- Over the last 3 years, PVAL has delivered higher annualized returns.
Side-by-side comparison
| PVAL | PCRB | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.36% |
| Fund size (AUM) | $10.1B | $7M |
| Since | 2021 | 2023 |
| Dividend yield | 1.00% | 9.54% |
| Asset class | equity | fixed income |
| Region | north america | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | +33.6% | +5.3% |
| CAGR 3Y | +24.1% | +3.9% |
| CAGR 5Y | N/A | N/A |
| Sharpe 3Y | 1.41 | 0.08 |
| Volatility 1Y | 10.94% | 3.79% |
| Max drawdown | -16.64% | -7.20% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PVAL and PCRB
Explore further